Lazebnik L B, Zvenigorodskaia L A, Khomeriki S G, Efremov L I, Cherkashova E A
Eksp Klin Gastroenterol. 2009(3):110-6.
In the article is presented the case of development of medicinal hepatitis as result of irrational use of statin treatment at patient with Ischemic heart disease and nonalcoholic Fatty Liver Disease against morbid obesity. The clinical observation reflects the necessity of usage of liver protectors in prevention of possible side effects of hypolipidemic statin treatment and emphasizes the advantage of double cholesterol inhibition.
本文介绍了一名患有缺血性心脏病、非酒精性脂肪性肝病且病态肥胖的患者，因不合理使用他汀类药物治疗而发生药物性肝炎的病例。临床观察反映了使用肝脏保护剂预防降血脂他汀类药物治疗可能产生的副作用的必要性，并强调了双重胆固醇抑制的优势。
